BROSSARD, QUEBEC, CANADA — (Marketwire) — 10/04/11 — DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, is pleased to announce the appointment of Mr Richard B. Baxter to the Board of Directors.A co-founder of New Health Capital Partners in New York City, Mr. Baxter was previously the co-head of Drawbridge Special Opportunities Health Care Group at Fortress Investme
BROSSARD, QUEBEC, CANADA — (Marketwire) — 07/19/11 — DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, is pleased to announce it has received US Food and Drug Administration (FDA) 510(k) clearance for its CARA technology.DIAGNOS has attained several key regulatory and compliance milestones in the past 12 months, including ISO 9001 certification, ISO 13485 certific
